China NMPA Product Recall - Implantable Cardiac Resynchronization Defibrillator (ICD)

Sorin Medical (Shanghai) Co., Ltd. has initiated a voluntary Level 1 recall of specific implantable cardiac resynchronization defibrillators and implantable cardiodefibrillators. This action, reported on May 8, 2017, under the National Medical Products Administration (NMPA) framework, addresses a critical product defect. The primary issue identified is a faulty defibrillator lead, which leads to device oversensing. This malfunction causes the defibrillator capacitor to charge repeatedly, ultimately resulting in accelerated battery depletion. A significant consequence of this issue is the device's inability to be detected when required, posing a serious health risk to patients. The recall is a proactive measure by Sorin Medical (Shanghai) Co., Ltd. to mitigate potential hazards associated with these medical devices. A Level 1 classification indicates that the use of these products may cause serious adverse health consequences or death. The company has formally reported this event and has committed to removing the affected products from distribution. Consumers and healthcare providers are directed to the "Medical Device Recall Event Report Form" for comprehensive details regarding the specific models, specifications, and batch numbers of the affected devices. This recall ensures compliance with NMPA regulations and prioritizes patient safety.